Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons

12 Aug 2024

Abstract excerpt

INTRODUCTION: Adult dermatomyositis (DM) and juvenile dermatomyositis (JDM) are rare autoimmune diseases with characteristic skin rashes, weakness, and other systemic features. Upregulated interferon signaling has been consistently described in both adult and juvenile DM which makes janus kinase inhibitors (jakinibs) an attractive therapeutic agent that has a targeted mechanism of action. AREAS COVERED: Herein is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Rheumatoid Arthritis Research and Therapies
Share to Spondyloarthritis Studies and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39136388
DOI: 10.1080/14656566.2024.2392021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisonsPMID 39136388Read ↗

Successful management with Janus kinase inhibitor tofacitinib in refractory juvenile dermatomyositis: a pilot study and literature reviewSemantic proximity Read ↗

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositisSemantic proximity Read ↗

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactiveSemantic proximity Read ↗

Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.Semantic proximity Read ↗

Recent advances in juvenile idiopathic inflammatory myopathies.Semantic proximity Read ↗

Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult DermatomyositisSemantic proximity Read ↗

The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.Semantic proximity Read ↗

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Semantic proximity Read ↗

Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.Semantic proximity Read ↗

Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.Semantic proximity Read ↗

Immunopathogenesis of juvenile dermatomyositis.Semantic proximity Read ↗

Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.